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Abstract
Background: Breast milk transmission of HIV-1 remains a major route of pediatric infection. Defining the characteristics of
viral variants to which breastfeeding infants are exposed is important for understanding the genetic bottleneck that occurs
in the majority of mother-to-child transmissions. The blood-milk epithelial barrier markedly restricts the quantity of HIV-1 in
breast milk, even in the absence of antiretroviral drugs. The basis of this restriction and the genetic relationship between
breast milk and blood variants are not well established.
Methodology/Principal Findings: We compared 356 HIV-1 subtype C gp160 envelope (env) gene sequences from the
plasma and breast milk of 13 breastfeeding women. A trend towards lower viral population diversity and divergence in
breast milk was observed, potentially indicative of clonal expansion within the breast. No differences in potential N-linked
glycosylation site numbers or in gp160 variable loop amino acid lengths were identified. Genetic compartmentalization was
evident in only one out of six subjects in whom contemporaneously obtained samples were studied. However, in samples
that were collected 10 or more days apart, six of seven subjects were classified as having compartmentalized viral
populations, highlighting the necessity of contemporaneous sampling for genetic compartmentalization studies. We found
evidence of CXCR4 co-receptor using viruses in breast milk and blood in nine out of the thirteen subjects, but no evidence
of preferential localization of these variants in either tissue.
Conclusions/Significance: Despite marked restriction of HIV-1 quantities in milk, our data indicate intermixing of virus
between blood and breast milk. Thus, we found no evidence that a restriction in viral genotype diversity in breast milk
accounts for the genetic bottleneck observed following transmission. In addition, our results highlight the rapidity of HIV-1
env evolution and the importance of sample timing in analyses of gene flow.
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Introduction
Studies of HIV-1 variants in blood indicate that regardless of
transmission route, descendents of a single virion establish
infection in the new host [1,2,3,4,5,6,7,8]. Transmitted viruses
are also distinguished by almost exclusive use of the CCR5 co-
receptor, and non-subtype B founder strains have envelopes with
shorter variable loops and fewer N-linked glycosylation sites
[6,8,9,10,11,12,13]. The factors that govern this selection are
unknown. Most transmissions occur across mucosal surfaces lined
by highly selective epithelial barriers, which produce a variety of
factors contributing to a distinct immunologic milieu. Levels of
HIV-1 in these transmitting compartments (e.g., genital fluids and
breast milk) are usually much lower than those in blood
[14,15,16], but few studies have addressed how mucosal restriction
contributes to the apparent transmission genetic bottleneck.
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blood and those in mucosal transmitting compartments is
important for understanding the dynamics of transmission as well
as for the design of vaccines and other prevention strategies [17].
Breast milk transmission remains a major source of pediatric
HIV-1 infection particularly in sub-Saharan Africa, where 90% of
pediatric HIV-1 infections occur [18,19]. The content of milk is
dynamically and tightly regulated; the types and activation state of
breast milk cells, as well as antibodies, cytokines, and chemokines,
are distinct from contemporaneously obtained blood [20,21]. Even
in the absence of antiretroviral therapy, the amount of HIV-1 in
breast milk is usually 10–100 fold less than that present in plasma,
which suggests limited exchange of virus between these two sites
[14]. The degree of immunologic and biochemical compartmental-
ization between blood and milk strongly suggests that HIV-1 strains
would also be compartmentalized, i.e., there would be a restriction
of viral passage (and consequent gene flow) [22]. Tissue compart-
mentalization has been reported for other sites such as cerebral
spinal fluid, brain, the male and female genital tracts, lymphoid
cells, blood monocytes, and the lung [23,24,25,26,27,28,29].
Evidence for virologic compartmentalization in the colostrum has
been found in small ruminants [30] and SIV [31], but human
studies involving viral compartmentalization in breast milk have
been limited and contradictory [32,33,34,35].
We sought to characterize the extent to which breast milk
variants were distinct from viruses circulating in the blood. We
compared viral diversity and divergence between blood and breast
milk, as well as viral populations between the right and left breast.
We assessed whether breast milk was enriched for a ‘‘transmis-
sible’’ viral phenotype, i.e., CCR5-tropic variants, and as
previously suggested for non-subtype-B transmissions, with shorter
variable loops and fewer potential N-linked glycosylation sites
[6,8,9,10,11,12,13]. We also compared the susceptibility of plasma
and breast milk HIV envelopes to two entry inhibitors. Finally,
given HIV’s extraordinary evolutionary rates and the inherent
difficulties in obtaining samples at the time of transmission, we
investigated the relationship between sampling time and virologic
compartmentalization using five distinct algorithms.
Materials and Methods
Subject enrollment, sample collection, and processing
Samples were obtained from 13 subjects participating in the
Zambia Exclusive Breastfeeding Study (ZEBS) (Table 1). ZEBS
was a randomized clinical trial designed to assess the impact of
short-term exclusive breastfeeding on HIV-1 transmission and
child mortality [19,36]. All women signed informed consent.
ZEBS was approved by Human Subjects Committees at the
investigators’ institutions in the US (Boston University, Columbia
University, University of Alabama, Birmingham and Childrens
Hospital Los Angeles) and by the University of Zambia Research
Ethics Committee. Laboratory specimens were completely anon-
ymized and unlinked.
All of the women received single-dose nevirapine (sdNVP)
peripartum, but were otherwise antiretroviral drug (ARV)-naı ¨ve.
Plasma and peripheral blood mononuclear cells (PBMC) were
separated from whole blood by centrifugation. Milk collected
separately from both breasts was centrifuged and the cell-free
supernatant analyzed [37]. None of the women had signs or
symptoms of mastitis prior to or at the time of breast milk
collection.
HIV-1 RNA levels in plasma (PL) were determined by the
Roche Amplicor assay, while breast milk levels were determined
by the Roche Ultrasensitive assay (Roche Diagnostics, Branch-
burg, New Jersey), which we previously validated for HIV
quantification in breast milk (BM) [37]. Breast milk sodium
concentrations were measured with an ion-selective electrode
(Beckman Coulter Synchron LX20: Beckman Coulter, Fullerton,
CA).
RNA extraction, reverse transcription, PCR, cloning, and
sequencing
Amplification, cloning, and sequencing of complete gp160 env
from PL and milk from each breast were performed as previously
described [6] with the following modifications. In order to avoid
resampling of the same viral template after PCR, multiple
independent PCRs were performed at limiting dilution or near-
Table 1. CD4+ T cell count at time of study entry, viral load at sequence sample time, and number of unique gp160 sequences.
Subject
ID
# Days between PL
and BM sampling
a
CD4+T
cells
Plasma Viral Load
(copies/mL)
BML
b Viral Load
(copies/mL)
BMR
c Viral Load
(copies/mL)
# PL
sequences
# BML
sequences
# BMR
sequences
31 0 163 131,175 4,111 2,971 11 2 8
21 0 55 242,813 20,687 14,726 10 8 13
32 0 134 235,196 3,987 10,570 13 16 10
7 0 317 75,933 25,694 17,625 12 12 8
33 0 82 437,545 1,294 1,885 13 7 10
10 0 300 663,850 23,862 387 9 11 1
34 10 172 150,449 32,131 11,274 9 8 10
17 15 291 51,349 3,448 7,518 15 5 0
35 31 419 100,187 11,940 24,440 13 6 4
14 43 94 375,319 637 1,538 13 8 9
1 102 76 300,000 11,340 74,970 9 5 6
3 115 94 206,763 3,272 3,019 11 2 10
16 141 118 211,792 20,207 18,277 17 10 12
aPL always sampled previous to BM.
bBML = Milk from the Left Breast.
cBMR = Milk from the Right Breast.
doi:10.1371/journal.pone.0010213.t001
Breast Milk HIV
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was used in the analysis [38,39]. All sequences were checked for
cross-contamination via ViroBLAST [40] against published and
local databases, and by observing that sequences from each subject
clustered separately from every other subject in a Jukes-Cantor
phylogenetic tree calculated in Seaview [41] using an alignment of
all sequences from all subjects. No evidence of sample mix-up or
contamination was observed (data not shown).
Phylogenetic analysis
Nucleotide sequences were aligned with MUSCLE v3.7 [42]
and refined manually within MacClade v4.08 software (Sinauer
Associates, Inc., Sunderland, MA). Four subtype C reference
sequences (accession numbers AY772699, U52953, U46016, and
AF067155) were included in each subject’s alignment for use as an
out-group to root the trees. Ambiguously aligned regions due to
extreme variability were excluded when calculating phylogenetic
trees. Maximum likelihood trees were calculated in PhyML [43]
using the online tool DIVER (http://indra.mullins.microbiol.
washington.edu/cgi-bin/DIVER/diver.cgi), which implemented
the evolutionary model GTR+I+G for all subjects. Diversity of
viral sequences for each tissue within each subject was calculated
in DIVER as pairwise distances under the previously estimated
maximum likelihood model between all sequences within each
tissue. Divergence of viral sequences for each tissue within each
subject was calculated as the genetic distance between each
sequence and the most recent common ancestor (MRCA) of the
examined sequences, as calculated in DIVER. Statistical compar-
isons between PL and BM diversity were performed using the two-
sample tests for comparing intra-individual sequence diversity
between populations [44] (http://www.scharp.org/users/adecamp/
diverstest/runtests.php); comparisons within each individual were
calculated using the Tpoolmedian test, which accounts for the
multiple comparisons inherent in a pairwise diversity matrix, while
the comparison between PL and BM among all of the subjects
pooled was performed with the Tsubjmean test, which treats the
averages of the pairwise distances within each individual
(accounting for multiple comparisons) as the observations.
Divergence comparisons were made using the Wilcoxon Rank
Sums test for within-individual comparisons. A generalized
estimating equations (GEE) model with exchangeable correlation
matrix was used for the pooled BM vs. PL divergence comparison,
which accounted for repeated measures from multiple individuals.
Shannon entropy scores [45] were calculated for each position in
the protein alignment using the Entropy2 software (http://www.
hiv.lanl.gov/content/sequence/ENTROPY/entropy.html).
Tests for compartmentalization
Five methods were used to determine viral sequence compart-
mentalization between PL and BM variants [46,47,48,49]. Four of
the tests were based on the topology of the phylogenetic trees; one
test relied on genetic distances between sequences. The four
phylogenetically-derived methods for detecting compartmentali-
zation were: (1) Slatkin-Maddison (SM), which determines the
minimum number of migration events between two populations
based on the tree topology; (2) Simmonds Association Index (AI),
which assesses the degree of population structure, weighting the
contribution of each internal node based on how deep it is in the
tree, and; Correlation Coefficients, either by (3) length of branches
‘‘r’’ or (4) by number of branches ‘‘rb’’. The correlation coefficients
tests examine any two sequences in a tree to determine whether or
not they originate from the same compartment by examining tree
structure and distances, i.e., the cumulative genetic distances
between sequences (the length of branches) (r), or the number of
tree branches separating the sequences (rb). The distance-based
method used was the Nearest Neighbor statistic (Snn), a measure
of how often the ‘‘nearest neighbor,’’ or sequence with the shortest
distance, from any given sequence is from the same tissue.
Permutation tests of 1000 randomizations were performed for
each type of analyses and p-values were calculated. Statistics and
compartmentalization tests were implemented in HyPhy as
described [50,51].
We also screened each alignment for recombination, since this
could confound compartmentalization [50]. For each subject in
which no compartmentalization was observed, we used a genetic
algorithm approach [52] implemented as the GARD tool in
DataMonkey (http://www.datamonkey.org/) to detect recombi-
nation breakpoints. Each non-recombinant fragment defined by
these breakpoints was then analyzed separately for compartmen-
talization using the previous methods.
We plotted the individual Snn score, Association Index,
correlation coefficients r and rb, as calculated above for each
subject, versus the number of days between PL and BM sampling,
and determined whether there was a linear correlation between
these values and the interval using the Spearman’s Rho test.
Aligned gp160 protein sequences from PL and BM were also
analyzed for tissue-specific amino acids using the Viral Epidemi-
ology Signature Pattern Analysis (VESPA) [53] (http://www.hiv.
lanl.gov/content/sequence/VESPA/vespa.html).
Envelope V3 loop genotypic prediction of NSI/SI
phenotype
The V3 loop region was analyzed to predict syncytium-inducing
phenotype via the subtype-C-specific Web PSSM [54] (http://
indra.mullins.microbiol.washington.edu/webpssm/).
Potential N-Linked glycosylation sites (PNGS) and amino
acid lengths
N-linked glycosylation sites were predicted using N-glycosite
[55] (http://www.hiv.lanl.gov/content/hiv-db/GLYCOSITE/
glycosite.html). The number of amino acids in full-length gp160
and within specific regions of gp120 was tallied for each sequence.
Statistical comparisons between PL and BM in each individual
were calculated using the Wilcoxon Rank Sums test, while
statistical comparisons between PL and BM for pooled data were
performed using a Generalized Estimating Equations (GEE) model
accounting for repeated measures from multiple subjects.
Nucleotide sequence accession numbers
All sequences were submitted to GenBank under acce-
ssion numbers HM036739-HM37037, GU939062-GU939098,
GU939143-GU939146, GU939148, GU939150-GU939154, and
GU939162-GU939171.
Phenotypic analysis of BM and PL Env
PL and BM full length Env from 11 women (5 of whom had PL
and BM sequences which initially scored as compartmentalized
under the previously mentioned tests) were compared for their
sensitivity to the entry inhibitors Tak-779 and T-20 using the TZM-
bl single-cycle pseudotype assay as previously described [56].
Results
Levels of HIV-1 in BM compared to PL
To define the degree to which the breast epithelium restricted
the amount of HIV-1 in milk, we compared the amount of viral
RNA in PL and BM in over 600 lactating women (Figure 1). As
Breast Milk HIV
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than that in PL.
Subjects and samples
To compare the genetic characteristics of BM and PL HIV-1
env, we amplified and cloned full-length gp160 genes from both
tissues in chronically HIV-1 subtype C infected women [19,36].
The clinical characteristics of these women are summarized in
Table 1. A total of 356 full-length gp160 sequences from the 13
women were obtained. Although we attempted to amplify at least
10 clones per tissue site, the low amplifiable copy number of viral
RNA from BM precluded reaching this goal in some instances.
This, along with specimen availability, also resulted in non-
contemporaneous sampling in some instances. Sequences from
contemporaneous PL and BM samples were collected from six of
the subjects (Subjects 31, 21, 32, 7, 33, and 10), while there was an
interval of between 10 and 141 days between PL and BM
collection in the other 7 subjects (Subjects 34, 17, 35, 14, 1, 3, and
16) (Table 1). Milk samples from right and left breast were
collected at the same time in all subjects. All subjects were
exclusively breastfeeding at the time of sample collection.
Phylogenetic analysis of HIV-1 compartmentalization in BM
Viral variants in PL were compared to those in BM from the
right and left breast. In four individuals, two or fewer sequences
were obtained from either breast, preventing further comparison.
In the remaining nine women, BM viral populations were
phylogenetically indistinguishable between the left and right
breast, regardless of whether there was compartmentalization
between PL and BM (data not shown). Analysis of BM variants (11
BML and 10 BMR) obtained at a separate time point in Subject
17 also revealed no difference (sequences from this time point were
not used in any other analysis). Thus, we grouped sequences from
the right and left breasts together and used all available BM
sequences from each individual for the remaining analyses.
Maximum likelihood trees were calculated (Figures 2 and 3) and
datasets were analyzed for compartmentalization. For each
subject, if the compartmentalization classifications determined by
the different methods were not concordant, we took the majority
consensus approach as previously described [51]. Sequences from
only one out of the six contemporaneously sampled subjects
(Subject 10) were classified as compartmentalized under these
criteria (Table 2), and examination of the trees by eye shows
sequences from tissues to be heavily intermixed in most of these
subjects (Figure 2). However, six out of the seven non-
contemporaneously-sampled subjects were classified as compart-
mentalized (Table 2), consistent with the patterns observed in the
trees (Figure 3), suggesting significant viral evolution over relatively
short intervals. These data strongly indicate that compartmental-
ization analyses be performed on contemporaneous samples.
Figure 1. Plasma and breast milk viral load. Viral loads determined by Roche Amplicor (PL) and Roche Amplicor Ultrasensitive (BM) assays. Gray
lines are means.
doi:10.1371/journal.pone.0010213.g001
Breast Milk HIV
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by GARD) separately, results were the same, except in non-
contemporaneously-sampled Subject 35 sequences, in which
compartmentalization was detected in two of six breakpoint-
delineated fragments (data not shown).
To further highlight the importance of contemporaneous
sampling in compartmentalization testing, we found a correlation
between the number of days between PL and BM sampling and
several qualitative measures of compartmentalization (Figure 4).
We plotted these values against the number of days between PL
and BM sampling for all 13 subjects and found a significant linear
correlation between the sampling interval and the Snn score, the
AI, and the correlation coefficient rb. This further demonstrates
that non-contemporaneously sampled subjects should not be
evaluated for compartmentalization, as the results are likely to be
confounded by viral evolution during the sampling interval.
Sequence diversity and divergence of PL and BM HIV-1
populations
We examined pairwise genetic diversity and divergence from
the subjects’ MRCA in the six contemporaneously sampled
subjects only. The node of the tree at which the MRCA was
calculated for each subject is indicated in Figure 2. These analyses
were not performed on non-contemporaneously obtained samples
since data on length of infection and other confounders were not
available. Nucleotide diversity between tissues was significantly
different in two out of the six subjects (Subjects 32 and 7), and in
both of these individuals, PL exhibited higher diversity compared
with BM (Figure 5A). We pooled all subjects’ PL diversity values
and compared them to all subjects’ BM diversity values and found
no significant difference overall, though there was a trend for BM
having less diversity than PL (p=0.086) (Figure 5B).
We calculated the genetic distance from each sequence to the
MRCA as a measure of potential viral evolution and compared
BM to PL. In two subjects, PL was significantly more divergent
from the MRCA than BM (Subjects 31 and 32) (Figure 5C). When
pooling all subjects’ PL divergence values and comparing them to
all subjects’ BM divergence values, BM was less divergent than PL
overall (p=0.048) (Figure 5D).
The extent of amino acid (AA) variability was measured using
site-specific Shannon Entropy scores [53]. Subject-specific patterns
differed between PL and BM, most often in regions of extreme
variability and ambiguous alignment; however, no consistent
pattern in AA variability across individuals was identified.
Likewise, when we looked for signature motifs by calculating the
frequency of AA at each site using VESPA, we identified intra-
individual signature sites distinguishing PL and BM but no inter-
host signature pattern was found.
Figure 2. Maximum likelihood trees of region gp160, PL and BM samples obtained contemporaneously. All trees were calculated under
the GTR+G+I model, rooted with 4 subtype C reference sequences obtained from LANL sequence database. In all subjects, HIV-1 RNA sequences from
the left breast (white circles) and from the right breast (gray circles) were intermixed. The scale at the bottom left of each tree corresponds to the
number of substitutions per site (for example, 0.01=1 substitution per 100 sites).
doi:10.1371/journal.pone.0010213.g002
Breast Milk HIV
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populations
We counted the number of potential N-linked glycosylation
(PNG) sites in PL and BM clones. No significant differences were
observed in the total number of PNG over the entire gp160 region,
except in one subject where fewer PNG were observed in milk
compared to plasma (Subject 34) (data not shown). When the
analysis was restricted to the V1 to V4 region, where most PNG
occur, four subjects had significantly fewer PNG in BM than in PL
(Subjects 34, 17, 1, and 3), while one subject had significantly more
PNG in BM than in PL (Subject 16) (data not shown). However,
when examined in aggregate, no difference in the number of BM
and PL PNG were observed in gp160. The same held true when
each region (V1, V2, C2, V3, C3, V4, C4, V5, and V1 to V4) was
analyzed separately.
Length of variable regions of HIV-1 env in PL and BM
We counted the number of amino acids in gp160 sequences in
the two tissues in each subject. Two subjects had significantly
shorter gp160 sequences in the BM (Subjects 34 and 3). When we
examined the V1 to V4 region, sequences were shorter in BM than
PL in four subjects (Subjects 33, 34, 1, and 3), while sequences
were longer in BM in one subject (Subject 16). However,
comparison of pooled PL to BM in aggregate showed that
gp160 and V1 to V4 sequences from BM were not significantly
different than those from PL (data not shown); the same was true
when examining variable regions separately (V1, V2, V3, V4, and
V5).
Prediction of syncytium-inducing phenotype
A subtype C position-specific scoring matrix of V3 amino acid
sequences (WebPSSM) was used to predict syncytia-inducing (SI)
variants. SI variants were predicted in sequences from 9 of 13
subjects (all except subjects 31, 32, 17, and 3) (Figure 6). SI
variants were a minority of the viral population in four of these
nine, detected in only one or two BM or PL sequences (Subjects
21, 34, 35, and 14), with SI variants predicted in BM only in three
of the four. SI variants were found in over 45% of BM variants in
Subjects 7, 10, and 16, while 100% of the BM and PL sequences
were predicted to be SI in Subject 33. In no case were SI variants
predicted in PL but not in BM.
Phenotypic Characteristics of Plasma and Breast Milk Env
One hundred and fifty-eight clones from the PL and BM of 11
women were compared for their sensitivity to the entry inhibitors
to Tak-779 and T-20. (Subjects 16 and 34 were not included). The
mean IC50 of PL variants to Tak-779 was 0.0234 ug/mL (std
error=0.006) and was significantly higher than that of BM, which
had a mean IC50 of 0.0165 ug/mL (std error=0.006), (p=0.003).
However, when stratified by compartmentalization classification,
Figure 3. Maximum likelihood trees of region gp160, PL samples obtained previous to BM samples. All trees were calculated under the
GTR+G+I model, rooted with 4 subtype C reference sequences obtained from LANL sequence database. In all subjects, HIV-1 RNA sequences from the
left breast (white circles) and from the right breast (gray circles) were intermixed. The scale at the bottom left of each tree corresponds to the number
of substitutions per site (for example, 0.01=1 substitution per 100 sites).
doi:10.1371/journal.pone.0010213.g003
Breast Milk HIV
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compartmentalized women. No differences in susceptibility to T-
20 were found overall or when the women were stratified by
compartmentalization classification.
Discussion
Defining the characteristics of HIV-1 variants in a transmitting
mucosal compartment may offer important clues to understanding
the nature of the genetic bottleneck observed during transmission
[1,2,4,5,6,7,8,38,57]. Despite its importance in pediatric HIV
infection, only a few studies have characterized HIV-1 variants in
breast milk, and the results are conflicting. Two small studies
reported virologic compartmentalization (6,7); however, these
studies focused on a very short region of env, did not employ
methodologies to avoid sequence resampling, and defined com-
partmentalization on the basis of visual inspection of trees. In
contrast, a study using a heteroduplex-tracking assay (HTA), which
has the ability to sample a large number of V1V2 variants [34],
found no differences between PL and BM viral populations. We
therefore sought to characterize HIV-1 in BM and PL in a much
larger cohort and analyzed the entire env gene, using conditions
explicitly designed to avoid sequence template resampling.
The immunologic milieu of breast milk is clearly distinct from
that in blood and contains high concentrations of HIV-1 specific T
cells, antibodies, cytokines, chemokines, and innate factors that
modulate HIV-1 transmission risk [58,59,60]. Given clear
immunologic compartmentalization [61] and the markedly lower
amounts of HIV-1 in breast milk [14] (Figure 1), we hypothesized
that virologic compartmentalization would exist between BM and
Table 2. Results of different compartmentalization tests.
Subject
ID
Sampling
interval (days)
aSM
br
crb
dAI
eSnn
31 0 0.232 0.113 0.065 0.758 0.670
21 0 0.118 0.885 0.469 0.969 0.022
32 0 0.102 0.001 0.029 0.393 0.118
7 0 0.372 0.003 0.016 0.943 0.142
33 0 0.008 0.008 0.007 0.449 0.707
10 0 0.648 0.409 0.774 0.466 0.259
34 10 0.024 0.001 0.003 0.386 0.018
17 15 0.003 0.015 0.004 0.038 ,0.001
35 31 0.162 0.158 0.036 0.839 0.185
14 43 0.006 0.040 0.002 0.292 ,0.001
11 0 2 ,0.001 0.001 0.001 0.005 ,0.001
31 1 5 ,0.001 0.066 0.038 0.008 0.005
16 141 ,0.001 0.001 0.001 0.001 ,0.001
Values are p-values obtained from randomization tests. P,0.05 was considered
evidence of compartmentalization.
aSM = Slatkin-Maddison.
br = Correlation coefficient by length of branches.
crb = Correlation coefficient by number of branches.
dAI = Association Index.
eSnn = Nearest neighbor statistic.
doi:10.1371/journal.pone.0010213.t002
Figure 4. Correlation between sampling interval and measures of compartmentalization. (A) Snn score vs. sampling interval; Snn scores
close to 1 indicate segregated populations, while scores close to 0.5 indicate mixed populations. (B) Simmonds Associative Index (AI) vs. sampling
interval; the AI is based on a grouping score (weighted by position in the tree) in which higher AI = less grouping of sequences from same tissue in
the tree. (C and D) Generalized correlation coefficient rb and r vs. sampling interval; rb and r offer a way to correlate the number of internal nodes (rb)
or branch length (r) between two sequences in a tree with the information about whether or not they were isolated from the same compartment.
P-values from Spearman’s Rho tests indicate significant linear correlations in A, B, and C.
doi:10.1371/journal.pone.0010213.g004
Breast Milk HIV
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sequences from the BM and PL of 13 women using limiting
dilution and multiple independent PCR amplifications to
minimize both template resampling and PCR-product recombi-
nation. A few samples were amplified using single genome
amplification approaches [62]; however, limitations in sample
quantity and cost precluded widespread use of this technique.
Since there is no consensus on the optimal approach for evaluating
virologic compartmentalization we employed five different tests
[50]. Using a majority consensus approach, only one of six subjects
with contemporaneously obtained samples was classified as having
compartmentalized virus (Table 2), despite an almost 100-fold
difference in HIV-1 RNA levels between PL and BM.
We sought to identify factors that may have confounded our
ability to detect virologic compartmentalization. Breast epithelial
tight junctions are ‘‘leaky’’ during changes in lactation practice as
well as during inflammation (mastitis). All samples were collected
from women who were exclusively breastfeeding, none had a
history of breast pathology, and when available, had BM sodium
levels that were not markedly elevated [63]. Thus, all milk samples
were obtained from women in whom breast epithelial tight
junctions would be predicted to be closed. Also, the low levels of
BM HIV-1 RNA support an intact breast epithelium. Recombi-
nation between parental sequences from each tissue type could
also mask compartmentalization [50]. However, even when the
analysis of milk sequences was restricted to regions bordered by
recombination breakpoints, no evidence of compartmentalization
was detected using the various tests.
Since we could only examine samples that contained relatively
high levels of HIV-1, by necessity our study population was biased.
InstudiesoftemporaldynamicsofbreastmilkHIV-1RNAlevels,at
four months post-partum 57% of women in ZEBS had BM viral
loads ,50 copies per ml, and in those with quantifiable levels the
median value was only 364 copies per ml [14]. Thus, the women
included in this analysis were not ‘‘typical,’’ and temporal
fluctuations in viral populations coupled with the relatively small
numbers of clones we amplified may have confounded our ability to
detect compartmentalization. Indeed, some studies indicate that
compartmentalization may be more easily detected when viral loads
are low, particularly in subjects who are on antiretroviral therapy
Figure 5. Diversity and divergence in breast milk and plasma. (A) Comparing mean diversity of virus in breast milk and plasma HIV-1 RNA
gp160 sequences of contemporaneously sampled subjects. Triangles = plasma, circles = breast milk; star = significant difference between plasma
and breast milk diversity, p-values from Wilcoxon rank sums test. (B) Comparing diversity in breast milk and plasma in all contemporaneously
sampled patients in aggregate, using Gilbert, Rossini, and Shankarappa’s method for comparing intra-individual genetic sequence diversity between
populations. Black lines are means. (C) Comparison of mean divergence of virus in BM and PL within contemporaneously sampled subjects. P-values
from Wilcoxon rank sums test. (D) Comparison of viral divergence between the BM and PL of all contemporaneously sampled subjects in aggregate.
P-value obtained using a GEE model. Black lines are means.
doi:10.1371/journal.pone.0010213.g005
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load could allow for variants within BM to replicate separately and
appear as distinct from that in blood, while high viral loads in all
tissues could cause a ‘‘swamping’’ of signal, in which plasma virus
flooding the tissues obscures detection of within-tissue replication.
We found that sampling interval can have a striking effect on
compartmentalization tests. When sequences from PL and BM
samples were collected 10 or more days apart, the majority (6 of 7)
were classified as compartmentalized (Table 2); if recombination
was taken into account, all seven non-contemporaneously sampled
subjects met criteria for compartmentalization. In addition, there
was a correlation between the sampling time interval and 3 of 4
qualitative measures of compartmentalization, so that the greater
the amount of time between sampling, the more frequently
compartmentalization was detected (Figure 3). However, signifi-
cant compartmentalization was detected even in the subjects with
the smallest intervals between sampling (10 to 31 days), reflecting
the high rate of HIV-1 evolution. Differences in compartmental-
ization were also reflected functionally in differential susceptibility
to Tak-779. These analyses underscore the importance of
obtaining contemporaneous samples in compartmentalization
analyses. These data also highlight the importance of longitudinal
studies, which could elucidate the direction and rate of viral
migration between these tissues not only during lactation but also
in response to inflammatory stimuli [65].
Though the difference between BM and PL viral diversity was
not significant (Figure 5B), there was a trend for BM to be less
diverse than PL, which could be the result of the multiple factors
native to BM that may impede multi-variant outgrowth (such as
antibodies, mucin, natural ligands to CCR5 that competitively
inhibit HIV-1 binding, and chemokines and cytokines that create a
hostile environment for HIV-1 [58,59,60]). Another factor that
could contribute to a decrease in overall BM diversity is the
presence of two or more identical or nearly identical sequences
within individuals’ BM. Nine subjects had from two to nine BM
sequences which were identical or nearly identical (despite careful
efforts to avoid resampling and contamination), which could be
indicative of localized clonal bursts of virus production [15] within
the BM environment immediately prior to sampling, either due to
host restrictions on replication, or to transient effects of single-dose
nevirapine, as has been found in subjects on suppressive ART
[66,67]. Divergence in BM was also slightly lower than in PL
(Figure 5D). This difference could be indicative of a different host-
immunologic response within this tissue resulting in the persistence
of infected cells for longer periods – if archival sequences are able
to persist in this environment they would drag the average
divergence down compared to more divergent, contemporane-
ously circulating virus in the PL [22].
A primary focus of our study was to determine whether BM was
enriched for variants that have been identified in newly infected
persons. In subtype C sexual transmission, variants that establish
infection have shorter variable loops, fewer potential N-linked
glycosylation sites, and use CCR5 for entry [6,8,9,10,11]. We
found virtually no difference between PL and BM in either PNG
counts or lengths, in gp160 or by region; this overall lack of any
defining feature of BM in this respect is concordant with our
inability to detect compartmentalization in most subjects, and
reinforces the observation that HIV-1 in breast milk appears to be
very similar to that found in plasma. Newly transmitted viruses are
also distinguished by almost exclusive use of CCR5. Using a
subtype C phenotype-prediction method [54] we detected SI
variants in the breast milk of 9 of 13 women. Thus, our data
indicate that CCR5-using variants are not preferentially selected
for within BM, suggesting that this tissue may not be responsible
for the major bottleneck that occurs upon transmission [10].
We detected evidence for a far higher incidence of SI-using
variants in our data set than initially expected. HIV-1 subtype C
viruses have historically been reported at lower frequencies of
CXCR4-using strains than in other group M subtypes [68,69,70]. A
switch from R5 tropism to X4 tropism has been associated with
disease progression in other subtypes [71,72], and while this
association has not been established in subtype C [73], the relatively
high proportion of SI variants in our dataset may reflect a very
biased population – all our subjects had advanced HIV disease and
transmitted virus to their children. It may also represent an overall
evolutionary change in the epidemic of subtype-C HIV-1, in which
CXCR4-tropism (or CCR5/CXCR4 dual tropism) is increasing in
subtype C, as has been suggested [74].
In conclusion, within the limitation on inference imposed by the
number of women examined here (N=13), the genetic bottleneck
observed during HIV transmission does not appear to be mediated
by selection within breast milk. Furthermore, our studies highlight
HIV-1’s rapid evolution and the importance of well characterized
and appropriately timed sampling in both genotypic and phenotypic
studies of HIV variants. Further studies defining factors that restrict
HIV entry into breast milk remain important for understanding and
preventing milk-borne pediatric HIV-1 transmission.
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